Dr Nomathemba Chandiwana is a clinician-scientist with experience in conducting large-scale HIV clinical trials in Africa. Her research is focused on investigating better, safer, and cost-effective antiretroviral treatment options for people with HIV, particularly among women who represent the majority of people with HIV in Africa.
Through the experience gained from HIV, she is one of a team of South African colleagues who are investigating effective and accessible therapeutics for COVID-19 patients, as well as the evolving problem of long-COVID. Other recent work has been on research and advocacy into health concerns beyond HIV such as obesity and obstructive sleep apnoea and with HIV.
